Understanding the heterogeneity and dysfunction of HDL in chronic kidney disease: insights from recent reviews

Inker LA, Astor BC, Fox CH, Isakova T, Lash JP, Peralta CA, et al. KDOQI us commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis 2014;63:713–35. https://doi.org/10.1053/j.ajkd.2014.01.416.

Article  PubMed  Google Scholar 

GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of Disease Study 2019. Lancet. 2020;396:1223–49. https://doi.org/10.1016/S0140-6736(20)30752-2.

Article  Google Scholar 

Thomas MC, Cooper ME, Zimmet P. Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease. Nat Rev Nephrol. 2016;12(2):73–81. https://doi.org/10.1038/nrneph.2015.173.

Article  CAS  PubMed  Google Scholar 

Navaneethan SD, Zoungas S, Caramori ML, Chan JCN, Heerspink HJL, Hurst C, et al. Diabetes management in chronic kidney disease: Synopsis of the KDIGO 2022 clinical practice Guideline Update. Ann Intern Med. 2023;176(3):381–7. https://doi.org/10.7326/M22-2904.

Article  PubMed  Google Scholar 

Ma I, Guo M, Muruve D, Benediktsson H, Naugler C. Sociodemographic associations with abnormal estimated glomerular filtration rate (eGFR) in a large Canadian city: a cross-sectional observation study. BMC Nephrol. 2018;19(1):198. https://doi.org/10.1186/s12882-018-0991-5.

Article  PubMed  PubMed Central  Google Scholar 

Roehm B, Weiner DE. Blood pressure targets and kidney and cardiovascular disease: same data but discordant guidelines. Curr Opin Nephrol Hypertens. 2019;28(3):245–50. https://doi.org/10.1097/MNH.0000000000000492.

Article  PubMed  PubMed Central  Google Scholar 

Zewinger S, Kleber ME, Rohrer L, Lehmann M, Triem S, Jennings RT, et al. Symmetric dimethylarginine, high-density lipoproteins and cardiovascular disease. Eur Heart J. 2017;38(20):1597–607. https://doi.org/10.1093/eurheartj/ehx118.

Article  CAS  PubMed  Google Scholar 

Poole AP, Finnis ME, Anstey J, Bellomo R, Bihari S, Biradar V, et al. The effect of a liberal approach to glucose control in critically ill patients with type 2 diabetes: a multicenter, parallel-group, open-label randomized clinical trial. Am J Respir Crit Care Med. 2022;206(7):874–82. https://doi.org/10.1164/rccm.202202-0329OC.

Article  PubMed  Google Scholar 

Brown JC, Gerhardt TE, Kwon E. Risk factors for coronary artery disease. 2023. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023. PMID: 32119297.

Ter Braake AD, Shanahan CM, de Baaij JHF. Magnesium counteracts vascular calcification: Passive interference or active modulation? Arterioscler Thromb Vasc Biol. 2017;37(8):1431–45. https://doi.org/10.1161/ATVBAHA.117.309182.

Article  CAS  PubMed  Google Scholar 

Zhan Y, Zhang R, Li G. Effect of magnesium on vascular calcification in chronic kidney disease patients: a systematic review and meta-analysis. Ren Fail. 2023;45(1):2182603. https://doi.org/10.1080/0886022X.2023.2182603.

Article  PubMed  PubMed Central  Google Scholar 

Brandenburg VM, Reinartz S, Kaesler N, Krüger T, Dirrichs T, Kramann R, et al. Slower progress of aortic valve calcification with vitamin K supplementation: Results from a prospective interventional proof-of-concept study. Circulation. 2017;135(21):2081–2083. https://doi.org/10.1161/CIRCULATIONAHA.116.027011. Erratum in: Circulation. 2020;141(3):e54.

Ridker PM, MacFadyen JG, Glynn RJ, Koenig W, Libby P, Everett BM, et al. Inhibition of interleukin-1β by canakinumab and cardiovascular outcomes in patients with chronic kidney disease. J Am Coll Cardiol. 2018;71(21):2405–14. https://doi.org/10.1016/j.jacc.2018.03.490.

Article  CAS  PubMed  Google Scholar 

Calabresi L, Simonelli S, Conca P, Busnach G, Cabibbe M, Gesualdo L, et al. Acquired lecithin: cholesterol acyltransferase deficiency as a major factor in lowering plasma HDL levels in chronic kidney disease. J Intern Med. 2015;277(5):552–61. https://doi.org/10.1111/joim.12290. Epub 2014 Aug 1. PMID: 25039266.

Kontush A, Chapman MJ. Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis. Pharmacol Rev. 2006;58(3):342–74. https://doi.org/10.1124/pr.58.3.1. PMID: 16968945.

Rader DJ, Tall AR. The not-so-simple HDL story: Is it time to revise the HDL cholesterol hypothesis? Nat Med. 2012;18(9):1344–6. https://doi.org/10.1038/nm.2937. PMID: 22961164.

Nicholls SJ, Nelson AJ. HDL and cardiovascular disease. Pathology. 2019;51(2):142–147. https://doi.org/10.1016/j.pathol.2018.10.017. Epub 2019 Jan 3. PMID: 30612759.

Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 1955;34(9):1345–53. https://doi.org/10.1172/JCI103182. PMID: 13252080; PMCID: PMC438705.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Asztalos BF, Schaefer EJ. High-density lipoprotein subpopulations in pathologic conditions. Am J Cardiol. 2003;91(7A):12E–17E. https://doi.org/10.1016/s0002-9149(02)03383-0. PMID: 12679198.

Forte T, Norum KR, Glomset JA, Nichols AV. Plasma lipoproteins in familial lecithin: cholesterol acyltransferase deficiency: structure of low and high density lipoproteins as revealed by elctron microscopy. J Clin Invest. 1971;50(5):1141–8. https://doi.org/10.1172/JCI106586. PMID: 5552411; PMCID: PMC292037.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tall AR, Small DM, Shipley GG, Lees RS. Apoprotein stability and lipid-protein interactions in human plasma high density lipoproteins. Proc Natl Acad Sci U S A. 1975;72(12):4940–2. https://doi.org/10.1073/pnas.72.12.4940. PMID: 174082; PMCID: PMC388849.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Segrest JP. Amphipathic helixes and plasma lipoproteins: thermodynamic and geometric considerations. Chem Phys Lipids. 1977;18(1):7–22. https://doi.org/10.1016/0009-3084(77)90023-8. PMID: 832339.

Segrest JP, Feldmann RJ. Amphipathic helixes and plasma lipoproteins: a computer study. Biopolymers. 1977;16(9):2053–65. https://doi.org/10.1002/bip.1977.360160916. PMID: 901926.

Kane JP, Malloy MJ. Prebeta-1 HDL and coronary heart disease. Curr Opin Lipidol. 2012;23(4):367–71. https://doi.org/10.1097/MOL.0b013e328353eef1. PMID: 22517613.

Ishida BY, Frolich J, Fielding CJ. Prebeta-migrating high density lipoprotein: quantitation in normal and hyperlipidemic plasma by solid phase radioimmunoassay following electrophoretic transfer. J Lipid Res. 1987;28(7):778–86. PMID: 3114402.

Article  CAS  PubMed  Google Scholar 

Castro GR, Fielding CJ. Early incorporation of cell-derived cholesterol into pre-beta-migrating high-density lipoprotein. Biochemistry. 1988;27(1):25–9. https://doi.org/10.1021/bi00401a005. PMID: 3126809.

Hara H, Yokoyama S. Interaction of free apolipoproteins with macrophages. Formation of high density lipoprotein-like lipoproteins and reduction of cellular cholesterol. J Biol Chem. 1991;266(5):3080–6. PMID: 1993681.

Bodzioch M, Orsó E, Klucken J, Langmann T, Böttcher A, Diederich W, et al. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat Genet. 1999;22(4):347–51. https://doi.org/10.1038/11914. PMID: 10431237.

Brooks-Wilson A, Marcil M, Clee SM, Zhang LH, Roomp K, van Dam M, et al. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet. 1999;22(4):336–45. https://doi.org/10.1038/11905. PMID: 10431236.

Rust S, Rosier M, Funke H, Real J, Amoura Z, Piette JC, et al. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat Genet. 1999;22(4):352–5. https://doi.org/10.1038/11921. PMID: 10431238.

Nagata KO, Nakada C, Kasai RS, Kusumi A, Ueda K. ABCA1 dimer-monomer interconversion during HDL generation revealed by single-molecule imaging. Proc Natl Acad Sci U S A. 2013;110(13):5034–9. https://doi.org/10.1073/pnas.1220703110. Epub 2013 Mar 11. PMID: 23479619; PMCID: PMC3612634.

Article  PubMed  PubMed Central  Google Scholar 

Qian H, Zhao X, Cao P, Lei J, Yan N, Gong X. Structure of the human lipid exporter ABCA1. Cell. 2017;169(7):1228–39.e10. Epub 2017 Jun 8. PMID: 28602350.

Article  CAS  PubMed  Google Scholar 

Francone OL, Gurakar A, Fielding C. Distribution and functions of lecithin: cholesterol acyltransferase and cholesteryl ester transfer protein in plasma lipoproteins. Evidence for a functional unit containing these activities together with apolipoproteins A-I and D that catalyzes the esterification and transfer of cell-derived cholesterol. J Biol Chem. 1989;264(12):7066–72. PMID: 2496125.

Article  CAS  PubMed  Google Scholar 

Rothblat GH, Phillips MC. High-density lipoprotein heterogeneity and function in reverse cholesterol transport. Curr Opin Lipidol. 2010;21(3):229–38. https://doi.org/10.1097/mol.0b013e328338472d. PMID: 20480549; PMCID: PMC3215082.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ong KL, Cochran BJ, Manandhar B, Thomas S, Rye KA. HDL maturation and remodelling. Biochim Biophys Acta Mol Cell Biol Lipids. 2022;1867(4):159119. https://doi.org/10.1016/j.bbalip.2022.159119. Epub 2022 Feb 2. PMID: 35121104.

Article  CAS  PubMed  Google Scholar 

Raman P, Khanal S. Leptin in atherosclerosis: Focus on macrophages, endothelial and smooth muscle cells. Int J Mol Sci. 2021;22(11):5446. https://doi.org/10.3390/ijms22115446. PMID: 34064112; PMCID: PMC8196747.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Atkinson D, Small DM. Recombinant lipoproteins: implications for structure and assembly of native lipoproteins. Annu Rev Biophys Biophys Chem. 1986;15:403–56. https://doi.org/10.1146/annurev.bb.15.060186.002155. PMID: 3521660.

Brouillette CG, Jones JL, Ng TC, Kercret H, Chung BH, Segrest JP. Structural studies of apolipoprotein A-I/phosphatidylcholine recombinants by high-field proton NMR, nondenaturing gradient gel electrophoresis, and electron microscopy. Biochemistry. 1984;23(2):359–67. https://doi.org/10.1021/bi00297a027. PMID: 6421314.

Deng S, Xu Y, Zheng L. HDL Structure. Adv Exp Med Biol. 2022;1377:1–11. https://doi.org/10.1007/978-981-19-1592-5_1. PMID: 35575917.

Kontush A, Lindahl M, Lhomme M, Calabresi L, Chapman MJ, Davidson WS. Structure of HDL: particle subclasses and molecular components. Handb Exp Pharmacol. 2015;224:3–51. https://doi.org/10.1007/978-3-319-09665-0_1. PMID: 25522985.

Jones MK, Gu F, Catte A, Li L, Segrest JP. Sticky and promiscuous, the Yin and Yang of apolipoprotein A-I termini in discoidal high-density lipoproteins: a combined computational-experimental approach. Biochemistry. 2011;50(12):2249–63. https://doi.org/10.1021/bi101301g. Epub 2011 Mar 4. PMID: 21329368; PMCID: PMC3119339.

Article  CAS  PubMed 

留言 (0)

沒有登入
gif